Bharat Biotech seeks DCGI nod to extend shelf life of Covaxin - Report - Android

New Delhi, Apr 25: Bharat Biotech has written to the India's drug regulator seeking extension of the shelf-life of its indigenously developed COVID-19 vaccine Covaxin from six to 24 months, sources said on Sunday. Covaxin, along with Covishield manufactured by Serum